Search | IOVS | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Qualitative effects of a novel nano-lipid artificial tear on tear lipid dynamics

Matthew James Kowalski; Jennifer Swingle Fogt; Peter Ewen King-Smith; Joseph T Barr

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3532. doi:

ARVO Annual Meeting Abstract June 2017

Evaluation of lipid layer thickness of the tears over the course of a day

Jennifer Swingle Fogt; Matthew James Kowalski; Nick Fogt; Peter Ewen King-Smith; Joseph T Barr

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4381. doi:

ARVO Annual Meeting Abstract April 2014

Increased health care utilization among patients with diabetic macular edema compared with diabetic patients without edema

Chris John Wallick; Ryan N Hansen; Joanna Campbell; Jonathan W Kowalski; Szilard Kiss; Sean D Sullivan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1751. doi:

ARVO Annual Meeting Abstract April 2014

Real World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data From a Large Health System

Joanna Campbell; Ashley L Cole; Arghavan Almony; Herbert Ingraham; Nancy M Holekamp; Steven Marks; Hitesh Chandwani; Jonathan W Kowalski; Szilard Kiss

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3065. doi:

ARVO Annual Meeting Abstract April 2014

Real-World Vision Outcomes in RVO Treated With Anti-VEGF Injections- An Analysis of EMR Data From a Large Health System

Hitesh Chandwani; Ashley L Cole; Joanna Campbell; Herbert Ingraham; Arghavan Almony; Szilard Kiss; Steven Marks; Jonathan W Kowalski; Nancy M Holekamp

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3919. doi:

ARVO Annual Meeting Abstract April 2014

Patient Adherence and Persistence with Topical Bimatoprost ® 0.01% and Bimatoprost ® 0.03%: an Analysis of Latanoprost Switchers

Jonathan W Kowalski; Joanna Campbell; Gail F Schwartz; Britni LaBounty

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):540. doi:

ARVO Annual Meeting Abstract June 2013

Patient Adherence and Persistence with Topical Ocular Hypotensive Therapy: a Claims-Based Comparison of Bimatoprost 0.01% and Travoprost with sofZia

Joanna Campbell; Gail Schwartz; Britni LaBounty; Jonathan Kowalski; Vaishali Patel

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4403. doi:

ARVO Annual Meeting Abstract June 2013

Real-World Utilization of Anti-VEGFs in Diabetic Macular Edema and Retinal Vein Occlusion: Injection Frequency, Patient Monitoring, and Concomitant Therapy Use

Szilard Kiss; Ying Liu; Joseph Brown; Nancy Holekamp; Arghavan Almony; Joanna Campbell; Jonathan Kowalski

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2172. doi:

Clinical Trials July 2013

Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis

PDF

Susan Lightman; Rubens Belfort, Jr.; Rupali K. Naik; Careen Lowder; C. Stephen Foster; Anne M. Rentz; Harry Cui; Scott M. Whitcup; Jonathan W. Kowalski; Dennis A. Revicki
TAGS: dexamethasone, implants, uveitis, posterior, vision, intravitreal implants
Invest. Ophthalmol. Vis. Sci.. 2013; 54(7):4864-4870. doi: https://doi.org/10.1167/iovs.12-10981

Includes: Supplemental Content

ARVO Annual Meeting Abstract March 2012

Real-world Utilization of Intravitreal Anti-Vascular Endothelial Growth Factor Agents in Common Retinal Diseases

Nancy M. Holekamp; Wei-Shi Yeh; Yifeng Chia; Szilárd Kiss; Arghavan Almony; Jonathan W. Kowalski

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4179. doi:

ARVO Annual Meeting Abstract April 2011

Normative Comparison of Patient-Reported Outcomes in Patients With Noninfectious Intermediate or Posterior Uveitis

Rupali K. Naik; Careen Y. Lowder; Sue Lightman; Anne M. Rentz; Jonathan Kowalski; C. Stephen Foster; Rubens Belfort, Jr.; Dennis Revicki; Scott M. Whitcup

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2729. doi:

ARVO Annual Meeting Abstract April 2011

Global Prevalence of Diabetic Retinopathy: Pooled Data from Population Studies from the United States, Australia, Europe and Asia

Tien Y. Wong; Joanne Yau; Sophie Rogers; Ryo Kawasaki; Ecosse L. Lamoureux; Meta-Eye Group; Jonathan Kowalski

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4818. doi:

ARVO Annual Meeting Abstract April 2011

Association Between Duration of Macular Edema and Clinical Outcomes in Patients with Retinal Vein Occlusion Following Treatment With Dexamethasone Intravitreal Implant

Wei-Shi D. Yeh; Julia A. Haller; Baruch D. Kuppermann; Paul Mitchell; Paolo Lanzetta; Scott M. Whitcup; Tien Y. Wong; Jonathan W. Kowalski

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3965. doi:

ARVO Annual Meeting Abstract April 2010

Efficacy of Dexamethasone Intravitreal Implant for the Treatment of Uveitis Based on Patient-Reported Vision Function Outcome Measures

R. K. Naik; H. Gelhorn; J. Kowalski; H. Cui; D. Revicki; C. Y. Lowder; R. Belfort, Jr.; C. Foster; S. Lightman; S. M. Whitcup

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5875. doi:

ARVO Annual Meeting Abstract April 2010

Effect of Dexamethasone Intravitreal Implant on Patient-Reported Visual Functioning for the Treatment of Macular Edema Following Retinal Vein Occlusion

J. Kowalski; A. Rentz; D. Revicki; R. Belfort, Jr.; J. A. Haller; C.-C. Liu; S. M. Whitcup

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4726. doi:

ARVO Annual Meeting Abstract April 2010

Normative Comparison of Generic- and Vision-Targeted Health-Related Quality of Life (HRQL)Outcomes in Patients With Vision Loss Due to Macular Edema Following Retinal Vein Occlusion

A. M. Rentz; J. Kowalski; D. Revicki; A. Loewenstein; M. S. Blumenkranz; Y. Yoon; S. M. Whitcup

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4728. doi:

ARVO Annual Meeting Abstract April 2009

Health State Utility Valuations Using Health States based on the Visual Function Questionnaire

J. Kowalski; J. Walt; B. Nafees; A. Rentz; D. Revicki; J. Brazier; R. Hays

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3760. doi:

ARVO Annual Meeting Abstract May 2008

Resource Utilization and Direct Medical Costs to Medicare for Beneficiaries With Incident Diabetic Macular Edema

L. Curtis; A. Shea; B. Hammill; J. Kowalski; A. Ravelo; P. Lee; K. Schulman

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3757. doi:

ARVO Annual Meeting Abstract May 2008

National Eye Institute Visual Function Questionnaire - 25-Item Reduction Using Rasch Analysis

B. Nafees; A. Rentz; D. A. Revicki; M. Meguro; J. Kowalski; J. Walt; J. Brazier; R. D. Hays

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4462. doi:

ARVO Annual Meeting Abstract May 2008

A Systematic Literature Review of Utilities Associated With Visual Acuity in Retinal Diseases

J. C. Hornberger; A. Shewade; J. W. Doberne; J. Kowalski; H. Nguyen

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4478. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Qualitative effects of a novel nano-lipid artificial tear on tear lipid dynamics

Evaluation of lipid layer thickness of the tears over the course of a day

Increased health care utilization among patients with diabetic macular edema compared with diabetic patients without edema

Real World Vision Outcomes in DME Treated with Anti-VEGF Injections - An Analysis of EMR Data From a Large Health System

Real-World Vision Outcomes in RVO Treated With Anti-VEGF Injections- An Analysis of EMR Data From a Large Health System

Patient Adherence and Persistence with Topical Bimatoprost ® 0.01% and Bimatoprost ® 0.03%: an Analysis of Latanoprost Switchers

Patient Adherence and Persistence with Topical Ocular Hypotensive Therapy: a Claims-Based Comparison of Bimatoprost 0.01% and Travoprost with sofZia

Real-World Utilization of Anti-VEGFs in Diabetic Macular Edema and Retinal Vein Occlusion: Injection Frequency, Patient Monitoring, and Concomitant Therapy Use

Vision-Related Functioning Outcomes of Dexamethasone Intravitreal Implant in Noninfectious Intermediate or Posterior Uveitis

Real-world Utilization of Intravitreal Anti-Vascular Endothelial Growth Factor Agents in Common Retinal Diseases

Normative Comparison of Patient-Reported Outcomes in Patients With Noninfectious Intermediate or Posterior Uveitis

Global Prevalence of Diabetic Retinopathy: Pooled Data from Population Studies from the United States, Australia, Europe and Asia

Association Between Duration of Macular Edema and Clinical Outcomes in Patients with Retinal Vein Occlusion Following Treatment With Dexamethasone Intravitreal Implant

Efficacy of Dexamethasone Intravitreal Implant for the Treatment of Uveitis Based on Patient-Reported Vision Function Outcome Measures

Effect of Dexamethasone Intravitreal Implant on Patient-Reported Visual Functioning for the Treatment of Macular Edema Following Retinal Vein Occlusion

Normative Comparison of Generic- and Vision-Targeted Health-Related Quality of Life (HRQL)Outcomes in Patients With Vision Loss Due to Macular Edema Following Retinal Vein Occlusion

Health State Utility Valuations Using Health States based on the Visual Function Questionnaire

Resource Utilization and Direct Medical Costs to Medicare for Beneficiaries With Incident Diabetic Macular Edema

National Eye Institute Visual Function Questionnaire - 25-Item Reduction Using Rasch Analysis

A Systematic Literature Review of Utilities Associated With Visual Acuity in Retinal Diseases

To View More...

You must be signed into an individual account to use this feature.